Get started
Author

Gavin Morrow

Varicella-Zoster Virus Productively Infects Mature Dendritic Cells and Alters Their Immune Function
2003 · Gavin Morrow, Barry Slobedman, et al. · Journal of Virology · 122
Varicella-Zoster Virus Infection of Human Dendritic Cells and Transmission to T Cells: Implications for Virus Dissemination in the Host
2001 · Allison Abendroth, Gavin Morrow, et al. · Journal of Virology · 120
Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen
2011 · Nicola Winstone, Aaron J. Wilson, et al. · Journal of Virology · 66
Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responses
2005 · Silvia Peretti, Andrew Shaw, et al. · Blood · 45
Current concepts of HIV transmission
2007 · Gavin Morrow, Laurence Vachot, et al. · Current HIV/AIDS Reports · 44
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
2022 · Amy S. Espeseth, Maoli Yuan, et al. · EBioMedicine · 24
A Multiplex Microsphere-Based Immunoassay Increases the Sensitivity of SIV-Specific Antibody Detection in Serum Samples and Mucosal Specimens Collected from Rhesus Macaques Infected with SIVmac239
2013 · Rebecca L.R. Powell, Ian Ouellette, et al. · BioResearch open access · 18
Current concepts of HIV transmission
2008 · Gavin Morrow, Laurence Vachot, et al. · Current Infectious Disease Reports · 15
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
2022 · Christopher L. Cooper, Gavin Morrow, et al. · Vaccines · 14
PDF
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials
2025 · Christopher L. Cooper, Gavin Morrow, et al. · EBioMedicine · 11
Mapping the antibody response to Lassa virus vaccination of non-human primates
2025 · Adrian S. Enriquez, Ruben Diaz Avalos, et al. · EBioMedicine · 7
The Stem of Vesicular Stomatitis Virus G Can Be Replaced With the HIV-1 Env Membrane-Proximal External Region Without Loss of G Function or Membrane-Proximal External Region Antigenic Properties
2014 · Ivo C. Lorenz, Hanh T. Nguyen, et al. · AIDS Research and Human Retroviruses · 6
Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector
2013 · Xinsheng Zhang, Olivia Wallace, et al. · Virology · 4
Evaluation of a replication-competent VSV-SIV vaccine candidate
2012 · CK Jurgens, G Morrow, et al. · Retrovirology · 2
PDF
Development of chimeric HIV Env immunogens for mucosal delivery with attenuated canine distemper virus (CDV) vaccine vectors
2012 · X Zhang, S Richlak, et al. · Retrovirology · 2
PDF
Safety and immunogenicity of a recombinant vesicular stomatitis virus-based Sudan virus vaccine in adults in the USA: a single-blind, first-in-human, dose-escalation phase 1 clinical trial
2026 · Dagna S Laufer, Arianna Marini, et al. · The Lancet Microbe · 1
An Intranasal Challenge Model in African Green Monkeys (Chlorocebus aethiops) for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5
2025 · Nadia Storm, Ming Lo, et al. · Viruses · 1
PDF
Corrigendum to “Membrane-bound SIV envelope trimmers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector” [Virology 446 (2013) 25–36]
2013 · Xinsheng Zhang, Olivia Wallace, et al. · Virology
PDF
Viral vector delivery of Env trimer immunogens
2012 · CL Parks, S Rabinovich, et al. · Retrovirology
PDF
Works count: 19
Citation count: 502
H-index: 10
I10-index: 10
Year
Topic
Type